Intech Biopharm Corporation (TPEX:6461)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.80
-0.20 (-0.80%)
Nov 13, 2026, 1:30 PM CST

Intech Biopharm Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-474.56-389.03-368.21-337.99-327.88-301.76
Depreciation & Amortization
92.4190.1886.3384.7385.2885.16
Other Amortization
1.091.091.020.090.080.14
Loss (Gain) From Sale of Investments
-0.030.38-0.28-0.93-0.3
Stock-Based Compensation
18.315.7614.6414.1316.8910.64
Other Operating Activities
33.0839.2528.0229.9222.5920.05
Change in Accounts Receivable
-0.164.87-6.150.5611.38-10.28
Change in Inventory
16.74-54.92-22.619.366.55-4.27
Change in Accounts Payable
-7.53-5.929.51-1.02-1.081.39
Change in Unearned Revenue
6.29-64.935.832.58-0.69-2.21
Change in Other Net Operating Assets
2.662.51-17.97-6.21-2.590.84
Operating Cash Flow
-312.87-361.13-269.22-204.13-190.39-200.61
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-38.5-61.89-43.62-30.04-10.74-21.31
Sale (Purchase) of Intangibles
-9.22-2.12--0.17-0.26-
Investment in Securities
107.5-137.5460-210-195-15
Other Investing Activities
2.664.0364.232.020.79
Investing Cash Flow
62.45-197.48422.37-235.98-203.98-35.52

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-80----
Long-Term Debt Issued
--2.0127270-
Total Debt Issued
510802.0127270-
Short-Term Debt Repaid
--80----30
Long-Term Debt Repaid
--24.19-2-2-15.1-
Lease Payments
-0.39-0.19----
Total Debt Repaid
-124.39-104.19-2-2-15.1-30
Net Debt Issued (Repaid)
385.61-24.190.0125254.9-30
Issuance of Common Stock
-433.91-4605.06300
Other Financing Activities
-33.36-32.44-32.44-31.98-21.26-18.08
Financing Cash Flow
352.25377.28-32.43453.02238.71251.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.49-0.520.20-0-0
Net Cash Flow
101.34-181.85120.9212.91-155.6615.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-351.37-423.02-312.84-234.17-201.13-221.91
Free Cash Flow Growth
------
Free Cash Flow Margin
-646.57%-393.41%-786.44%-905.98%-850.56%-570.48%
Free Cash Flow Per Share
-3.26-4.51-3.68-3.14-2.80-3.53
Levered Free Cash Flow
-234.08-330.52-206.2-150.09-108.35-137.16
Unlevered Free Cash Flow
-213.69-309.57-184.85-129.1-93.95-124.95
Free Cash Flow After Leases
-351.76-423.22-312.84-234.17-201.13-221.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
32.3632.3632.5132.1821.6818.2
Cash Income Tax Paid
--0.020.460.220.03-0
Change in Working Capital
17.99-118.4-31.45.2813.58-14.53